Home / Market News / $GCO

$GCO news and market catalysts

The 6 most recent market catalysts affecting $GCO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 1 high impact 3 bullish 2 bearish Retail - Footwear
Sep 3, 2026 Corporate Catalyst Bullish Impact 85
Genesco’s Turnaround Story Gets A Major Boost From Journeys
Genesco's Q2 fiscal 2027 results showed a significant improvement, with an adjusted loss of 83 cents per share, much narrower than the $1.37 consensus and the prior year. This beat…
Sep 3, 2026 Corporate Catalyst Neutral Impact 75
Transcript: Genesco Q2 2027 Earnings Conference Call
Genesco (GCO) reported Q2 2027 earnings that significantly exceeded expectations, primarily due to improved gross margins, increased full-price selling, and effective expense manag…
Sep 3, 2026 Corporate Catalyst Bearish Impact 75
Genesco shares are trading lower after the company reported better-than-expected Q2 financial results and raised its FY27 GAAP EPS guidance above estimates.
This headline presents a classic 'sell the news' scenario or indicates that the market had even higher expectations than the 'better-than-expected' results. Despite strong Q2 perfo…
Sep 3, 2026 Corporate Catalyst Bullish Impact 75
Genesco Raises FY2027 GAAP EPS Guidance from $2.32-$2.75 to $2.96-$3.39 vs $2.24 Est
Genesco (GCO) announced a substantial increase in its GAAP EPS guidance for fiscal year 2027, moving from a range of $2.32-$2.75 to $2.96-$3.39. This revised outlook is notably hig…
Sep 3, 2026 Corporate Catalyst Bearish Impact 75
Genesco Affirms FY2027 Adj EPS Guidance of $2.00-$2.40 vs $2.25 Est; Lowers FY2027 Sales Guidance from $2.412B-$2.436B to $2.387B vs $2.430B Est
Genesco (GCO) has affirmed its FY2027 adjusted EPS guidance, which is a positive signal for profitability expectations. However, the company simultaneously lowered its FY2027 sales…
Sep 3, 2026 Corporate Catalyst Bullish Impact 75
Genesco Q2 Adj. EPS $(0.83) Beats $(1.37) Estimate, Sales $529.858M Beat $527.260M Estimate
Genesco announced its Q2 earnings, reporting an adjusted loss per share of $(0.83), which was significantly better than the analyst estimate of $(1.37). Sales also exceeded expecta…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.